Aeterna Zentaris to Announce Fourth Quarter and Full Year 2011 Financial and Operating Results on March 27, 2012

^{Published on Tuesday, March 20th 2012 at 4:46 GMT by Market Wire}  

Aeterna Zentaris to Announce Fourth Quarter and Full Year 2011 Financial and Operating Results on March 27, 2012

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about AEZS

QUEBEC CITY, March 20, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: [ AEZS ]) (TSX: AEZ) (the "Company") will announce its fourth quarter and full year 2011 financial and operating results on Tuesday, March 27, 2012. The Company will host a conference call and webcast to discuss these results on Wednesday, March 28 at 8:30 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at [ www.aezsinc.com ] in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit [ www.aezsinc.com ].

SOURCE AETERNA ZENTARIS INC.